Levels of Serum Amyloid A, β2-MG and D-D in Patients with Acute Cerebral Infarction and Their Clinical Significances

doi:10.11748/bjmy.issn.1006-1703.2020.02.017

PDF(3549 KB)

Labeled Immunoassays and Clinical Medicine ›› 2020, Vol. 27 ›› Issue (2) : 262-266. DOI: 10.11748/bjmy.issn.1006-1703.2020.02.017

Levels of Serum Amyloid A, β2-MG and D-D in Patients with Acute Cerebral Infarction and Their Clinical Significances

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 27(2): 262-266 https://doi.org/10.11748/bjmy.issn.1006-1703.2020.02.017

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3549 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2019-10-13	2019-11-12	2020-02-25
Issue Date
2020-08-18

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS